In one word @honeyforme, "no".
Motley Fool quoted the BP report that gave a price indication consistent with a 171% rise IF certain milestones were met. Performance is yet to be measured against those milestones. The first could be this month (rheumatoid arthritis ). The second (cardiac failure) is expected to read out interim results Q1 of 2016.
Any follower with a fraction of understanding of this stock and an open mind knows that. You do waste peoples' time with pointless "contributions". I hate to use an ignore button but you do tempt.
JPM Initial report..., page-21
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.030(2.01%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $15.34M | 10.23M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 35231 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 29593 | 12 |
View Market Depth
| Last trade - 14.42pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |